SecBot SecBot
SECBOTREPLAY Home › Report › NIVF

NIVF · 79% discount equity offering

NewGenIvf Group Ltd · 424B5 filed Nov 20, 2026 at 09:00 ET

At the news

BEARISHIMPACT 7/10

424B5 filed Nov 20, 2026 at 09:00 ET

NewGenIvf Group Limited is conducting a deeply discounted firm-commitment underwritten offering of 1,150,570 Class A ordinary shares at $0.035 per share (a 79.4% discount to the $0.17 last reported sale price on November 18, 2026) and 70,278,000 pre-funded warrants at $0.03499 each. The offering raises approximately $2.5 million in gross proceeds ($2.095 million net), with $625,000 used to repurchase a portion of an outstanding convertible note. The offering is massively dilutive: the pre-funded warrants alone represent over 21x the current Class A shares outstanding, and the company faces imminent Nasdaq delisting risk after ten reverse stock splits with a cumulative ratio of ~17,280,000-to-1.

  • Offering of 1,150,570 Class A shares at $0.035/share, a 79.4% discount to the $0.17 last reported sale price on November 18, 2026
  • 70,278,000 pre-funded warrants offered at $0.03499 each, exercisable at $0.00001 per share, immediately exercisable with a 4.99% beneficial ownership limitation
  • Total gross proceeds of $2,499,297; net proceeds estimated at $2.095 million after underwriting discounts ($225,000) and estimated expenses ($180,000)
  • $625,000 of gross proceeds used to repurchase $584,112 principal amount of an outstanding senior convertible note

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access